tenofovir disoproxil maleate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
TENOFOVIR DISOPROXIL EMTRICITABINE VIATRIS 300/200 tenofovir disoproxil maleate 300 mg and emtricitabine 200 mg film coated tablet bottle
AUST R: 265834
Active ingredients:
emtricitabine
tenofovir disoproxil maleate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
20 May 2024
to
31 Jan 2025

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An unregistered product has been approved for supply under Section 19A. The approval holder Phero Pharma Pty Ltd can be contacted on 1800 720 020 for enquiries about supply.

TENOFOVIR DISOPROXIL VIATRIS tenofovir disoproxil maleate 300 mg film coated tablet bottle
AUST R: 261093
Active ingredients:
tenofovir disoproxil maleate

Dosage form:
Tablet, film coated

Sponsor:
Alphapharm Pty Ltd

Phone:
1800274276

From
10 Dec 2024
to
28 Feb 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic products are available.